Literature DB >> 23847105

Curcumin-free turmeric exhibits anti-inflammatory and anticancer activities: Identification of novel components of turmeric.

Bharat B Aggarwal1, Wei Yuan, Shiyou Li, Subash C Gupta.   

Abstract

Turmeric, a dried powder derived from the rhizome of Curcuma longa, has been used for centuries in certain parts of the world and has been linked to numerous biological activities including antioxidant, anti-inflammatory, anticancer, antigrowth, anti-arthritic, anti-atherosclerotic, antidepressant, anti-aging, antidiabetic, antimicrobial, wound healing, and memory-enhancing activities. One component of turmeric is curcumin, which has been extensively studied, as indicated by more than 5600 citations, most of which have appeared within the past decade. Recent research has identified numerous chemical entities from turmeric other than curcumin. It is unclear whether all of the activities ascribed to turmeric are due to curcumin or whether other compounds in turmeric can manifest these activities uniquely, additively, or synergistically with curcumin. However, studies have indicated that turmeric oil, present in turmeric, can enhance the bioavailability of curcumin. Studies over the past decade have indicated that curcumin-free turmeric (CFT) components possess numerous biological activities including anti-inflammatory, anticancer, and antidiabetic activities. Elemene derived from turmeric is approved in China for the treatment of cancer. The current review focuses on the anticancer and anti-inflammatory activities exhibited by CFT and by some individual components of turmeric, including turmerin, turmerone, elemene, furanodiene, curdione, bisacurone, cyclocurcumin, calebin A, and germacrone.
© 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Apoptosis; Cancer; Inflammation; Turmeric; Turmeric components

Mesh:

Substances:

Year:  2013        PMID: 23847105     DOI: 10.1002/mnfr.201200838

Source DB:  PubMed          Journal:  Mol Nutr Food Res        ISSN: 1613-4125            Impact factor:   5.914


  57 in total

Review 1.  Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases.

Authors:  Ajaikumar B Kunnumakkara; Devivasha Bordoloi; Ganesan Padmavathi; Javadi Monisha; Nand Kishor Roy; Sahdeo Prasad; Bharat B Aggarwal
Journal:  Br J Pharmacol       Date:  2016-10-21       Impact factor: 8.739

2.  Curcumin May (Not) Defy Science.

Authors:  Kathryn M Nelson; Jayme L Dahlin; Jonathan Bisson; James Graham; Guido F Pauli; Michael A Walters
Journal:  ACS Med Chem Lett       Date:  2017-05-11       Impact factor: 4.345

3.  Combination of Chinese and Western Medicine to Prevent and Reverse Resistance of Cancer Cells to Anticancer Drugs.

Authors:  Xin-Bing Sui; Tian Xie
Journal:  Chin J Integr Med       Date:  2019-11-09       Impact factor: 1.978

4.  The combination of dimethoxycurcumin with DNA methylation inhibitor enhances gene re-expression of promoter-methylated genes and antagonizes their cytotoxic effect.

Authors:  Hazem E Hassan; Jean-Arnaud Keita; Lawrence Narayan; Sean M Brady; Richard Frederick; Samuel Carlson; Karen C Glass; Senthil Natesan; Thomm Buttolph; Tamer E Fandy
Journal:  Epigenetics       Date:  2016-11-01       Impact factor: 4.528

5.  Local application of curcumin-loaded nanoparticles as an adjunct to scaling and root planing in periodontitis: Randomized, placebo-controlled, double-blind split-mouth clinical trial.

Authors:  Cindy Grace Pérez-Pacheco; Natalie Ap Rodrigues Fernandes; Fernando Lucas Primo; Antonio Claudio Tedesco; Emily Bellile; Belen Retamal-Valdes; Magda Feres; Morgana Rodrigues Guimarães-Stabili; Carlos Rossa
Journal:  Clin Oral Investig       Date:  2020-10-30       Impact factor: 3.573

Review 6.  Modulation of Inflammation by Plant-Derived Nutraceuticals in Tendinitis.

Authors:  Anna-Lena Mueller; Aranka Brockmueller; Ajaikumar B Kunnumakkara; Mehdi Shakibaei
Journal:  Nutrients       Date:  2022-05-12       Impact factor: 6.706

7.  Identification of a novel compound (β-sesquiphellandrene) from turmeric (Curcuma longa) with anticancer potential: comparison with curcumin.

Authors:  Amit Kumar Tyagi; Sahdeo Prasad; Wei Yuan; Shiyou Li; Bharat B Aggarwal
Journal:  Invest New Drugs       Date:  2015-11-02       Impact factor: 3.850

Review 8.  From Simple Mouth Cavities to Complex Oral Mucosal Disorders-Curcuminoids as a Promising Therapeutic Approach.

Authors:  Sosmitha Girisa; Aviral Kumar; Varsha Rana; Dey Parama; Uzini Devi Daimary; Saman Warnakulasuriya; Alan Prem Kumar; Ajaikumar B Kunnumakkara
Journal:  ACS Pharmacol Transl Sci       Date:  2021-03-17

9.  Direct pulmonary delivery of solubilized curcumin reduces severity of lethal pneumonia.

Authors:  Boya Zhang; Samantha Swamy; Sanjay Balijepalli; Sreehari Panicker; Jashitha Mooliyil; Matthew A Sherman; Jaakko Parkkinen; Krishnan Raghavendran; Madathilparambil V Suresh
Journal:  FASEB J       Date:  2019-09-17       Impact factor: 5.834

10.  Evidence That Tumor Microenvironment Initiates Epithelial-To-Mesenchymal Transition and Calebin A can Suppress it in Colorectal Cancer Cells.

Authors:  Constanze Buhrmann; Aranka Brockmueller; Choudhary Harsha; Ajaikumar B Kunnumakkara; Peter Kubatka; Bharat B Aggarwal; Mehdi Shakibaei
Journal:  Front Pharmacol       Date:  2021-07-02       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.